Cargando…
Glucocorticoid receptor-mediated cis-repression of osteogenic genes requires BRM-SWI/SNF()
Glucocorticoids are an effective therapy for a variety of severe inflammatory and autoimmune disorders; however, the therapeutic use of glucocorticoids is severely limited by their negative side effects, particularly on osteogenesis. Glucocorticoids regulate transcription by binding to the glucocort...
Autores principales: | Pico, Michael J., Hashemi, Sharareh, Xu, Fuhua, Nguyen, Kevin Hong, Donnelly, Robert, Moran, Elizabeth, Flowers, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440962/ https://www.ncbi.nlm.nih.gov/pubmed/28580390 http://dx.doi.org/10.1016/j.bonr.2016.07.006 |
Ejemplares similares
-
Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in
Differentiation
por: Flowers, Stephen, et al.
Publicado: (2009) -
The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors
por: Kahali, Bhaskar, et al.
Publicado: (2014) -
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development
por: Marquez-Vilendrer, Stefanie B., et al.
Publicado: (2016) -
Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits
por: Raab, Jesse R., et al.
Publicado: (2017) -
SWI/SNF‐Mediated Lineage Determination in Mesenchymal Stem Cells Confers Resistance to Osteoporosis
por: Nguyen, Kevin Hong, et al.
Publicado: (2015)